Cite
Supplementary Data from A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
MLA
Aaron R. Hansen, et al. Supplementary Data from A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0ccbdc81c6fbaa24fb7b359ab9512366&authtype=sso&custid=ns315887.
APA
Aaron R. Hansen, Lillian L. Siu, Geoffrey I. Shapiro, Liz Sainsbury, Myria Nikolaou, Michele Moschetta, Peter G. Mortimer, Ganesh Moorthy, Brijesh Maroj, Teresa Klinowska, George Hawkins, Steve Colebrook, Elza C. de Bruin, Simon T. Barry, Miguel Quintela-Fandino, Javier García-Carbacho, Richard D. Baird, Elisabeth I. Heath, Mark Linch, … Atish D. Choudhury. (2023). Supplementary Data from A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors.
Chicago
Aaron R. Hansen, Lillian L. Siu, Geoffrey I. Shapiro, Liz Sainsbury, Myria Nikolaou, Michele Moschetta, Peter G. Mortimer, et al. 2023. “Supplementary Data from A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0ccbdc81c6fbaa24fb7b359ab9512366&authtype=sso&custid=ns315887.